COVID-19 Information

Find all the information and updates relating to COVID-19 and the vaccines from our Medical Advisors, local authorities and reputable partners in a central location.

The information supplied is general only and it is recommended that you consult with your treating clinician before making any decisions regarding your individual health.

ATAGI Recommendation one the use of a 3rd primary dose of COVID-19 Vaccine

Published: 9 October 2021

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.


ITP Insights Webinar – Common ITP Questions

Published: 24 September 2021

ITP Australia, joined the UK ITP Support Association along with the PDSA in the latest instalment of the ITP Insights Webinar Series.

Together, along with leading Haematologists from each country, we answer some of the common questions ITP Patients have, receive an update on the COVID-19 vaccines, and learn about the latest initiative from the UK, on the Shared Decision Making Toolkit.


Published: 24 September 2021

Joint Statement from ATAGI and THANZ regarding the COVID-19 Vaccines

Published: 23 May 2021

A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.


ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

COVID-19 Vaccine Update – Recommendations from ATAGI

Published: 8 April 2021

ATAGI has released a number of recommendations relating to the COVID-19 Vaccine.

Based on the emerging evidence of the extremely rare adverse side effect of blood clots, which is estimated to impact 4-6 recipients of the AstraZeneca Vaccine per 1,000,000 doses, the Australian Technical Advisory Group on Immunisation (ATAGI), has made the following statement relating to the COVID-19 Vaccine Rollout.


Dr Norman Swan talks about COVID-19, the risks of Blood Clots and ITP

Published: 18 March 2021

Dr Norman Swan hosts an ABC podcast called ‘Coronacast’, where they talk all things COVID-19. In a recent episode, he talks about the vaccines, the occurrence of blood clots and ITP.

Australian health authorities and regulators have assured the public that there is currently no evidence to suggest the AstraZeneca coronavirus vaccine is not safe or is causing blood clots. It’s come in response to several European countries pausing the AstraZeneca vaccine rollout amid blood clot concerns.


Australian experts confident in AstraZeneca vaccine despite pause in Europe.

Published: 16 March 2021


7.30 with Leigh Sales (ABC), Dr Norman Swan discussed the the most scrutinised vaccine rollout in history, with the COVID-19 vaccine. 

Several European countries have paused their roll out of the Astra Zeneca vaccine after dozens of reports of blood clots and some deaths among the millions who have received it.


COVID-19 Vaccine Statement from our Australian Medical Advisors

Published: 12 February 2021

A statement from the ITP Australia Medical Advisory Board regarding the COVID-19 Vaccine.

Based on the current data available, ITP Australia’s Medical Advisory Board believe that at this time, the benefits of the SARS-Cov2 vaccines outweigh the risks and strongly favours vaccination of all adults, including those with pre-existing ITP.


International Updates

Learn more about the COVID-19 vaccines amongst our global partners.